nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—Hypercalcaemia—Medroxyprogesterone Acetate—uterine cancer	0.0238	0.0291	CcSEcCtD
Methyclothiazide—Glycosuria—Medroxyprogesterone Acetate—uterine cancer	0.0204	0.0249	CcSEcCtD
Methyclothiazide—SLC12A3—renal system—uterine cancer	0.0195	0.107	CbGeAlD
Methyclothiazide—CA2—exocrine gland—uterine cancer	0.0164	0.0906	CbGeAlD
Methyclothiazide—SLC12A1—epithelium—uterine cancer	0.016	0.0884	CbGeAlD
Methyclothiazide—SLC12A3—female reproductive system—uterine cancer	0.0156	0.086	CbGeAlD
Methyclothiazide—SLC12A1—renal system—uterine cancer	0.0149	0.082	CbGeAlD
Methyclothiazide—Vascular purpura—Progesterone—uterine cancer	0.0148	0.0181	CcSEcCtD
Methyclothiazide—Purpura—Progesterone—uterine cancer	0.0137	0.0168	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.0133	0.0162	CcSEcCtD
Methyclothiazide—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.0125	0.0152	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Dactinomycin—uterine cancer	0.0121	0.0148	CcSEcCtD
Methyclothiazide—Cramp muscle—Progesterone—uterine cancer	0.0119	0.0146	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.011	0.0134	CcSEcCtD
Methyclothiazide—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.0108	0.0132	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Progesterone—uterine cancer	0.0103	0.0126	CcSEcCtD
Methyclothiazide—Pneumonia—Progesterone—uterine cancer	0.0103	0.0125	CcSEcCtD
Methyclothiazide—CA1—renal system—uterine cancer	0.0102	0.0564	CbGeAlD
Methyclothiazide—Hyperuricaemia—Etoposide—uterine cancer	0.0101	0.0123	CcSEcCtD
Methyclothiazide—Jaundice—Progesterone—uterine cancer	0.00995	0.0122	CcSEcCtD
Methyclothiazide—Body temperature increased—Carboplatin—uterine cancer	0.0098	0.012	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Etoposide—uterine cancer	0.00951	0.0116	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00936	0.0114	CcSEcCtD
Methyclothiazide—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00902	0.011	CcSEcCtD
Methyclothiazide—Erythema multiforme—Progesterone—uterine cancer	0.00866	0.0106	CcSEcCtD
Methyclothiazide—CA1—female reproductive system—uterine cancer	0.00819	0.0452	CbGeAlD
Methyclothiazide—CA4—renal system—uterine cancer	0.00799	0.0441	CbGeAlD
Methyclothiazide—Malnutrition—Progesterone—uterine cancer	0.00798	0.00974	CcSEcCtD
Methyclothiazide—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00785	0.00959	CcSEcCtD
Methyclothiazide—Muscle spasms—Progesterone—uterine cancer	0.00767	0.00937	CcSEcCtD
Methyclothiazide—Hypercalcaemia—Epirubicin—uterine cancer	0.00753	0.0092	CcSEcCtD
Methyclothiazide—Vision blurred—Progesterone—uterine cancer	0.00752	0.00918	CcSEcCtD
Methyclothiazide—Pneumonia—Dactinomycin—uterine cancer	0.00726	0.00886	CcSEcCtD
Methyclothiazide—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00723	0.00883	CcSEcCtD
Methyclothiazide—Vertigo—Progesterone—uterine cancer	0.00717	0.00875	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00715	0.00874	CcSEcCtD
Methyclothiazide—CA2—epithelium—uterine cancer	0.00715	0.0394	CbGeAlD
Methyclothiazide—Hypercalcaemia—Doxorubicin—uterine cancer	0.00697	0.00851	CcSEcCtD
Methyclothiazide—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00695	0.00849	CcSEcCtD
Methyclothiazide—CA2—smooth muscle tissue—uterine cancer	0.00689	0.038	CbGeAlD
Methyclothiazide—CA2—decidua—uterine cancer	0.00675	0.0372	CbGeAlD
Methyclothiazide—Agranulocytosis—Dactinomycin—uterine cancer	0.00673	0.00822	CcSEcCtD
Methyclothiazide—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00664	0.00811	CcSEcCtD
Methyclothiazide—CA2—renal system—uterine cancer	0.00663	0.0366	CbGeAlD
Methyclothiazide—Anaphylactic shock—Progesterone—uterine cancer	0.00651	0.00795	CcSEcCtD
Methyclothiazide—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00649	0.00793	CcSEcCtD
Methyclothiazide—Glycosuria—Epirubicin—uterine cancer	0.00646	0.00789	CcSEcCtD
Methyclothiazide—CA4—female reproductive system—uterine cancer	0.0064	0.0353	CbGeAlD
Methyclothiazide—Anorexia—Progesterone—uterine cancer	0.00621	0.00758	CcSEcCtD
Methyclothiazide—CA2—mammalian vulva—uterine cancer	0.0062	0.0342	CbGeAlD
Methyclothiazide—Erythema multiforme—Dactinomycin—uterine cancer	0.00612	0.00748	CcSEcCtD
Methyclothiazide—Cramp muscle—Etoposide—uterine cancer	0.0061	0.00745	CcSEcCtD
Methyclothiazide—Glycosuria—Doxorubicin—uterine cancer	0.00598	0.0073	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.0059	0.00721	CcSEcCtD
Methyclothiazide—Paraesthesia—Progesterone—uterine cancer	0.00585	0.00714	CcSEcCtD
Methyclothiazide—CA4—female gonad—uterine cancer	0.00583	0.0321	CbGeAlD
Methyclothiazide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00578	0.00706	CcSEcCtD
Methyclothiazide—Decreased appetite—Progesterone—uterine cancer	0.00566	0.00691	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Epirubicin—uterine cancer	0.00564	0.00689	CcSEcCtD
Methyclothiazide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00562	0.00687	CcSEcCtD
Methyclothiazide—Constipation—Progesterone—uterine cancer	0.00557	0.0068	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Epirubicin—uterine cancer	0.00533	0.00651	CcSEcCtD
Methyclothiazide—CA2—female reproductive system—uterine cancer	0.00531	0.0293	CbGeAlD
Methyclothiazide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.0053	0.00647	CcSEcCtD
Methyclothiazide—Pneumonia—Etoposide—uterine cancer	0.00525	0.00642	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Doxorubicin—uterine cancer	0.00522	0.00637	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00518	0.00632	CcSEcCtD
Methyclothiazide—Urticaria—Progesterone—uterine cancer	0.00517	0.00632	CcSEcCtD
Methyclothiazide—Body temperature increased—Progesterone—uterine cancer	0.00515	0.00629	CcSEcCtD
Methyclothiazide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00513	0.00626	CcSEcCtD
Methyclothiazide—Jaundice—Etoposide—uterine cancer	0.00509	0.00622	CcSEcCtD
Methyclothiazide—Leukopenia—Dactinomycin—uterine cancer	0.00505	0.00616	CcSEcCtD
Methyclothiazide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00505	0.00616	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Doxorubicin—uterine cancer	0.00493	0.00602	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Epirubicin—uterine cancer	0.00491	0.006	CcSEcCtD
Methyclothiazide—Agranulocytosis—Etoposide—uterine cancer	0.00487	0.00595	CcSEcCtD
Methyclothiazide—CA2—female gonad—uterine cancer	0.00483	0.0267	CbGeAlD
Methyclothiazide—CA2—vagina—uterine cancer	0.0048	0.0265	CbGeAlD
Methyclothiazide—Hypersensitivity—Progesterone—uterine cancer	0.0048	0.00586	CcSEcCtD
Methyclothiazide—CA1—lymph node—uterine cancer	0.00479	0.0264	CbGeAlD
Methyclothiazide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00469	0.00572	CcSEcCtD
Methyclothiazide—Asthenia—Progesterone—uterine cancer	0.00467	0.00571	CcSEcCtD
Methyclothiazide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00466	0.0057	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Epirubicin—uterine cancer	0.00466	0.00569	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Doxorubicin—uterine cancer	0.00455	0.00555	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Dactinomycin—uterine cancer	0.00451	0.0055	CcSEcCtD
Methyclothiazide—Diarrhoea—Progesterone—uterine cancer	0.00445	0.00544	CcSEcCtD
Methyclothiazide—Erythema multiforme—Etoposide—uterine cancer	0.00443	0.00541	CcSEcCtD
Methyclothiazide—Anorexia—Dactinomycin—uterine cancer	0.00439	0.00536	CcSEcCtD
Methyclothiazide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00435	0.00531	CcSEcCtD
Methyclothiazide—Photosensitivity—Epirubicin—uterine cancer	0.00433	0.00528	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Doxorubicin—uterine cancer	0.00431	0.00526	CcSEcCtD
Methyclothiazide—Dizziness—Progesterone—uterine cancer	0.00431	0.00526	CcSEcCtD
Methyclothiazide—Vascular purpura—Epirubicin—uterine cancer	0.00425	0.00519	CcSEcCtD
Methyclothiazide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00423	0.00517	CcSEcCtD
Methyclothiazide—Vomiting—Progesterone—uterine cancer	0.00414	0.00506	CcSEcCtD
Methyclothiazide—Rash—Progesterone—uterine cancer	0.00411	0.00501	CcSEcCtD
Methyclothiazide—Dermatitis—Progesterone—uterine cancer	0.0041	0.00501	CcSEcCtD
Methyclothiazide—Headache—Progesterone—uterine cancer	0.00408	0.00498	CcSEcCtD
Methyclothiazide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00404	0.00493	CcSEcCtD
Methyclothiazide—Photosensitivity—Doxorubicin—uterine cancer	0.004	0.00489	CcSEcCtD
Methyclothiazide—Decreased appetite—Dactinomycin—uterine cancer	0.004	0.00489	CcSEcCtD
Methyclothiazide—Purpura—Epirubicin—uterine cancer	0.00394	0.00481	CcSEcCtD
Methyclothiazide—Vascular purpura—Doxorubicin—uterine cancer	0.00393	0.0048	CcSEcCtD
Methyclothiazide—Muscle spasms—Etoposide—uterine cancer	0.00392	0.00479	CcSEcCtD
Methyclothiazide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0039	0.00476	CcSEcCtD
Methyclothiazide—Nausea—Progesterone—uterine cancer	0.00387	0.00472	CcSEcCtD
Methyclothiazide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00375	0.00458	CcSEcCtD
Methyclothiazide—CA4—lymph node—uterine cancer	0.00374	0.0207	CbGeAlD
Methyclothiazide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00372	0.00454	CcSEcCtD
Methyclothiazide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00372	0.00454	CcSEcCtD
Methyclothiazide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.0037	0.00451	CcSEcCtD
Methyclothiazide—Vertigo—Etoposide—uterine cancer	0.00367	0.00448	CcSEcCtD
Methyclothiazide—Leukopenia—Etoposide—uterine cancer	0.00365	0.00446	CcSEcCtD
Methyclothiazide—Purpura—Doxorubicin—uterine cancer	0.00365	0.00445	CcSEcCtD
Methyclothiazide—Body temperature increased—Dactinomycin—uterine cancer	0.00364	0.00444	CcSEcCtD
Methyclothiazide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.0035	0.00428	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Epirubicin—uterine cancer	0.00347	0.00424	CcSEcCtD
Methyclothiazide—Hypersensitivity—Dactinomycin—uterine cancer	0.00339	0.00414	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Etoposide—uterine cancer	0.00333	0.00407	CcSEcCtD
Methyclothiazide—Asthenia—Dactinomycin—uterine cancer	0.0033	0.00403	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Etoposide—uterine cancer	0.00326	0.00398	CcSEcCtD
Methyclothiazide—Pancreatitis—Epirubicin—uterine cancer	0.00322	0.00393	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00321	0.00392	CcSEcCtD
Methyclothiazide—Anorexia—Etoposide—uterine cancer	0.00317	0.00388	CcSEcCtD
Methyclothiazide—Diarrhoea—Dactinomycin—uterine cancer	0.00315	0.00385	CcSEcCtD
Methyclothiazide—CA2—lymph node—uterine cancer	0.00311	0.0171	CbGeAlD
Methyclothiazide—Photosensitivity reaction—Epirubicin—uterine cancer	0.003	0.00366	CcSEcCtD
Methyclothiazide—Paraesthesia—Etoposide—uterine cancer	0.00299	0.00365	CcSEcCtD
Methyclothiazide—Pancreatitis—Doxorubicin—uterine cancer	0.00298	0.00364	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Epirubicin—uterine cancer	0.00296	0.00362	CcSEcCtD
Methyclothiazide—Pneumonia—Epirubicin—uterine cancer	0.00294	0.0036	CcSEcCtD
Methyclothiazide—Vomiting—Dactinomycin—uterine cancer	0.00293	0.00357	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.0029	0.00354	CcSEcCtD
Methyclothiazide—Rash—Dactinomycin—uterine cancer	0.0029	0.00354	CcSEcCtD
Methyclothiazide—Decreased appetite—Etoposide—uterine cancer	0.0029	0.00354	CcSEcCtD
Methyclothiazide—Jaundice—Epirubicin—uterine cancer	0.00285	0.00348	CcSEcCtD
Methyclothiazide—Constipation—Etoposide—uterine cancer	0.00285	0.00348	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00277	0.00339	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Doxorubicin—uterine cancer	0.00274	0.00335	CcSEcCtD
Methyclothiazide—Nausea—Dactinomycin—uterine cancer	0.00273	0.00334	CcSEcCtD
Methyclothiazide—Agranulocytosis—Epirubicin—uterine cancer	0.00273	0.00334	CcSEcCtD
Methyclothiazide—Pneumonia—Doxorubicin—uterine cancer	0.00272	0.00333	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00269	0.00328	CcSEcCtD
Methyclothiazide—Urticaria—Etoposide—uterine cancer	0.00265	0.00323	CcSEcCtD
Methyclothiazide—Jaundice—Doxorubicin—uterine cancer	0.00264	0.00322	CcSEcCtD
Methyclothiazide—Body temperature increased—Etoposide—uterine cancer	0.00263	0.00322	CcSEcCtD
Methyclothiazide—Agranulocytosis—Doxorubicin—uterine cancer	0.00253	0.00309	CcSEcCtD
Methyclothiazide—Erythema multiforme—Epirubicin—uterine cancer	0.00248	0.00303	CcSEcCtD
Methyclothiazide—Hypersensitivity—Etoposide—uterine cancer	0.00245	0.003	CcSEcCtD
Methyclothiazide—Asthenia—Etoposide—uterine cancer	0.00239	0.00292	CcSEcCtD
Methyclothiazide—Erythema multiforme—Doxorubicin—uterine cancer	0.0023	0.00281	CcSEcCtD
Methyclothiazide—Malnutrition—Epirubicin—uterine cancer	0.00229	0.00279	CcSEcCtD
Methyclothiazide—Diarrhoea—Etoposide—uterine cancer	0.00228	0.00278	CcSEcCtD
Methyclothiazide—Dizziness—Etoposide—uterine cancer	0.0022	0.00269	CcSEcCtD
Methyclothiazide—Muscle spasms—Epirubicin—uterine cancer	0.0022	0.00269	CcSEcCtD
Methyclothiazide—Vision blurred—Epirubicin—uterine cancer	0.00216	0.00263	CcSEcCtD
Methyclothiazide—Vomiting—Etoposide—uterine cancer	0.00212	0.00259	CcSEcCtD
Methyclothiazide—Malnutrition—Doxorubicin—uterine cancer	0.00212	0.00259	CcSEcCtD
Methyclothiazide—Agitation—Epirubicin—uterine cancer	0.0021	0.00257	CcSEcCtD
Methyclothiazide—Rash—Etoposide—uterine cancer	0.0021	0.00256	CcSEcCtD
Methyclothiazide—Dermatitis—Etoposide—uterine cancer	0.0021	0.00256	CcSEcCtD
Methyclothiazide—Headache—Etoposide—uterine cancer	0.00209	0.00255	CcSEcCtD
Methyclothiazide—Vertigo—Epirubicin—uterine cancer	0.00206	0.00251	CcSEcCtD
Methyclothiazide—Leukopenia—Epirubicin—uterine cancer	0.00205	0.0025	CcSEcCtD
Methyclothiazide—Muscle spasms—Doxorubicin—uterine cancer	0.00204	0.00249	CcSEcCtD
Methyclothiazide—Vision blurred—Doxorubicin—uterine cancer	0.00199	0.00244	CcSEcCtD
Methyclothiazide—Nausea—Etoposide—uterine cancer	0.00198	0.00242	CcSEcCtD
Methyclothiazide—Agitation—Doxorubicin—uterine cancer	0.00195	0.00238	CcSEcCtD
Methyclothiazide—Vertigo—Doxorubicin—uterine cancer	0.0019	0.00232	CcSEcCtD
Methyclothiazide—Leukopenia—Doxorubicin—uterine cancer	0.00189	0.00231	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Epirubicin—uterine cancer	0.00187	0.00228	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Epirubicin—uterine cancer	0.00183	0.00223	CcSEcCtD
Methyclothiazide—Anorexia—Epirubicin—uterine cancer	0.00178	0.00217	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Doxorubicin—uterine cancer	0.00173	0.00211	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Doxorubicin—uterine cancer	0.00169	0.00207	CcSEcCtD
Methyclothiazide—Paraesthesia—Epirubicin—uterine cancer	0.00168	0.00205	CcSEcCtD
Methyclothiazide—Anorexia—Doxorubicin—uterine cancer	0.00165	0.00201	CcSEcCtD
Methyclothiazide—Decreased appetite—Epirubicin—uterine cancer	0.00162	0.00198	CcSEcCtD
Methyclothiazide—Constipation—Epirubicin—uterine cancer	0.0016	0.00195	CcSEcCtD
Methyclothiazide—Paraesthesia—Doxorubicin—uterine cancer	0.00155	0.00189	CcSEcCtD
Methyclothiazide—Decreased appetite—Doxorubicin—uterine cancer	0.0015	0.00183	CcSEcCtD
Methyclothiazide—Urticaria—Epirubicin—uterine cancer	0.00148	0.00181	CcSEcCtD
Methyclothiazide—Constipation—Doxorubicin—uterine cancer	0.00148	0.0018	CcSEcCtD
Methyclothiazide—Body temperature increased—Epirubicin—uterine cancer	0.00148	0.0018	CcSEcCtD
Methyclothiazide—Hypersensitivity—Epirubicin—uterine cancer	0.00138	0.00168	CcSEcCtD
Methyclothiazide—Urticaria—Doxorubicin—uterine cancer	0.00137	0.00168	CcSEcCtD
Methyclothiazide—Body temperature increased—Doxorubicin—uterine cancer	0.00137	0.00167	CcSEcCtD
Methyclothiazide—Asthenia—Epirubicin—uterine cancer	0.00134	0.00164	CcSEcCtD
Methyclothiazide—Diarrhoea—Epirubicin—uterine cancer	0.00128	0.00156	CcSEcCtD
Methyclothiazide—Hypersensitivity—Doxorubicin—uterine cancer	0.00127	0.00155	CcSEcCtD
Methyclothiazide—Asthenia—Doxorubicin—uterine cancer	0.00124	0.00151	CcSEcCtD
Methyclothiazide—Dizziness—Epirubicin—uterine cancer	0.00123	0.00151	CcSEcCtD
Methyclothiazide—Vomiting—Epirubicin—uterine cancer	0.00119	0.00145	CcSEcCtD
Methyclothiazide—Diarrhoea—Doxorubicin—uterine cancer	0.00118	0.00144	CcSEcCtD
Methyclothiazide—Rash—Epirubicin—uterine cancer	0.00118	0.00144	CcSEcCtD
Methyclothiazide—Dermatitis—Epirubicin—uterine cancer	0.00118	0.00144	CcSEcCtD
Methyclothiazide—Headache—Epirubicin—uterine cancer	0.00117	0.00143	CcSEcCtD
Methyclothiazide—Dizziness—Doxorubicin—uterine cancer	0.00114	0.0014	CcSEcCtD
Methyclothiazide—Nausea—Epirubicin—uterine cancer	0.00111	0.00135	CcSEcCtD
Methyclothiazide—Vomiting—Doxorubicin—uterine cancer	0.0011	0.00134	CcSEcCtD
Methyclothiazide—Rash—Doxorubicin—uterine cancer	0.00109	0.00133	CcSEcCtD
Methyclothiazide—Dermatitis—Doxorubicin—uterine cancer	0.00109	0.00133	CcSEcCtD
Methyclothiazide—Headache—Doxorubicin—uterine cancer	0.00108	0.00132	CcSEcCtD
Methyclothiazide—Nausea—Doxorubicin—uterine cancer	0.00103	0.00125	CcSEcCtD
